Meta-analysis of associations between four polymorphisms in the matrix metalloproteinases gene and gastric cancer risk

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 3, 2014, Pages 1263-1267

  Yang, Teng Fei ^a   Guo, Lin ^a   Wang, Qiang ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Matrix metalloproteinases (MMPs); Meta analysis; Polymorphism; Risk

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MMP1 PROTEIN, HUMAN; MMP2 PROTEIN, HUMAN; MMP7 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN;

ARTICLE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; META ANALYSIS; PROMOTER REGION; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH TUMOR;

GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK; STOMACH NEOPLASMS;

EID: 84896839818     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.3.1263     Document Type: Article

References (30)

1. Alakus H, Afriani N, Warnecke-Eberz U, et al (2010). Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. World J Surg, 34, 2853-59.
2. Carneiro F, Huntsman D G, Smyrk T C, et al (2004). Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol, 203, 681-87.
3. Companioni O, Bonet C, Munoz X, et al (2013). Polymorphisms of H. pylori signaling pathway genes and gastric cancer risk in the European EPIC-eurgast cohort. Int J Cancer, 134, 92-101.
4. de Martel C, Ferlay J, Franceschi S, et al (2012). Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol, 13, 607-15.
5. Egeblad M, Werb Z (2002). New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer, 2, 161-74.
6. Fingleton B, Vargo-Gogola T, Crawford H C, et al (2001). Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis. Neoplasia, 3, 459-68.
7. Hu C, Wang J, Xu Y, et al (2013). Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP). gene and lung cancer risk: a meta-analysis. Gene, 517, 65-71.
8. Jin X, Kuang G, Wei LZ, et al (2005). No association of the matrix metalloproteinase 1 promoter polymorphism with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in northern China. World J Gastroenterol, 11, 2385-89.
9. Ke P, Wu ZD, Wen HS, et al (2013). Current evidence on associations between the MMP-7 (-181A>G). polymorphism and digestive system cancer risk. Asian Pac J Cancer Prev, 14, 2269-72.
10. Kim J, Pyun J A, Cho S W, et al (2011). Lymph node metastasis of gastric cancer is associated with the interaction between poly (ADP-ribose). polymerase 1 and matrix metallopeptidase 2. Dna Cell Biol, 30, 1011-17.
11. Kubben F J, Sier C F, Meijer M J, et al (2006). Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. Br J Cancer, 95, 744-51.
12. Lee Y Y, Derakhshan M H (2013). Environmental and lifestyle risk factors of gastric cancer. Arch Iran Med, 16, 358-65.
13. Li X, Qu L, Zhong Y, et al (2013). Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis. J Cancer Res Clin Oncol, 139, 1433-47.
14. Li Y, Sun DL, Duan YN, et al (2010). Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China. Mol Biol Rep, 37, 197-205.
15. Lin X D, Chen G, Li C, et al (2011). Association of polymorphism in matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 with genetic susceptibility of gastric cancer. Zhonghua Yu Fang Yi Xue Za Zhi, 45, 711-16.
16. Malik M A, Zargar S A, Mittal B (2011). Role of the metalloproteinase-7 (181A>G). polymorphism in gastric cancer susceptibility: a case control study in Kashmir valley. Asian Pac J Cancer Prev, 12, 73-76.
17. Matsumura S, Oue N, Kitadai Y, et al (2004). A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancer. J Cancer Res Clin Oncol, 130, 259-65.
18. Matsumura S, Oue N, Nakayama H, et al (2005). A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer. J Cancer Res Clin Oncol, 131, 19-25.
19. McColgan P, Sharma P (2009). Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects. Int J Cancer, 125, 1473-78.
20. Miao X, Yu C, Tan W, et al (2003). A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T). is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Cancer Res, 63, 3987-90.
21. Noe V, Fingleton B, Jacobs K, et al (2001). Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci, 114, 111-18.
22. Peng B, Cao L, Ma X, et al (2010). Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk. Mutagenesis, 25, 371-79.
23. Price S J, Greaves D R, Watkins H (2001). Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem, 276, 7549-58.
24. Rutter JL, Mitchell TI, Buttice G, et al (1998). A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res, 58, 5321-25.
25. Sugimoto M, Furuta T, Kodaira C, et al (2008). Polymorphisms of matrix metalloproteinase-7 and chymase are associated with susceptibility to and progression of gastric cancer in Japan. J Gastroenterol, 43, 751-61.
26. Wu CY, Wu MS, Chen YJ, et al (2007). Clinicopathological significance of MMP-2 and TIMP-2 genotypes in gastric cancer. Eur J Cancer, 43, 799-808.
27. Zhang B, Ye S, Herrmann SM, et al (1999). Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation, 99, 1788-94.
28. Zhang J, Jin X, Fang S, et al (2005). The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma. Carcinogenesis, 26, 1748-53.
29. Zhang X M, Miao X P, Xiong P, et al (2004). Association of functional polymorphisms in matrix metalloproteinase-2 (MMP-2). and MMP-9 genes with risk of gastric cancer in a Chinese population. Ai Zheng, 23, 1233-37.
30. Zhou P, Du LF, Lv GQ, et al (2011). Current evidence on the relationship between four polymorphisms in the matrix metalloproteinases (MMP). gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat, 127, 813-18.